CRI Logo
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Types
    • Cancer Types
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Clinical Accelerator
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Ways to Give
    • Fundraise
    • Events
    • Partnership
    • Contact
Donate
  • Brain Cancer Awareness Month: 2022 Immunotherapy Research Updates

    This Brain Cancer Awareness Month, discover new research, new treatments, and progress for a future immune to…

    May 3, 2022| CRI Staff
  • Melanoma Monday: 2022 Immunotherapy Research Updates

    This Melanoma Monday, discover new research, new treatments, and progress for a future immune to melanoma.

    May 2, 2022| CRI Staff
  • Head and Neck Cancer Awareness Month: 2022 Immunotherapy Research Updates

    This April for Head and Neck Cancer Awareness Month, discover the new research, new treatments, and progress…

    April 3, 2022| CRI Staff
  • Esophageal Cancer Awareness Month: 2022 Immunotherapy Research Updates

    This April for Esophageal Cancer Awareness Month, discover the new research, new treatments, and progress for a…

    April 2, 2022| CRI Staff
  • FDA Immunotherapy Approvals in 2022

    As drug development in cancer immunotherapy has accelerated, the U.S. Food and Drug Administration has made several…

    March 30, 2022| CRI Staff
  • Kidney Cancer Awareness Month: 2022 Immunotherapy Research Updates

    This March for Kidney Cancer Awareness Month, discover the patient perspectives, clinical trials, and progress for a…

    March 9, 2022| CRI Staff
  • Colorectal Cancer Awareness Month: 2022 Immunotherapy Research Updates

    This March for Colorectal Cancer Awareness Month, discover the latest clinical trials, research insights, and progress for…

    March 5, 2022| CRI Staff
  • Multiple Myeloma Awareness Month: 2022 Immunotherapy Research Updates

    This March for Multiple Myeloma Awareness Month, discover the latest treatments, research insights, and progress for a…

    March 2, 2022| CRI Staff
  • Crossing the Country to Cure Cancer

    Jarad Schofer became intrigued by the idea of walking across America and decided to raise money for…

    January 31, 2022| CRI Staff

Cancer Research Institute
29 Broadway, Floor 4

New York, NY  10006-3111

Facebook Icon
X icon
YouTube icon
LinkedIn icon
Instagram icon
Threads icon
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Type
    • Cancer Type
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Clinical Accelerator
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Donate
    • Ways to Give
    • Fundraise
    • Events
    • Partnership
    • Contact

Uniting for a World Immune to Cancer

  • Accessibility Statement
  • Privacy Policy
  • Terms & Conditions
  • Site Map

*Immunotherapy results may vary from patient to patient.

©2026, Cancer Research Institute